Genitourinary Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Genitourinary
| Protocol | COG AREN03B2 |
|---|---|
| Cancer Type: | Renal-Biology |
| Fast Facts |
Renal Tumors Classification, Biology, and Banking Study
Patients must be < 30 Years Old at the Time of Diagnosis
| Protocol | COG AREN1921 |
|---|---|
| Cancer Type: | Wilms |
| Fast Facts |
COG-AREN1921: Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
Patients must be ≤ 30 years old at study enrollment.
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
